Lens epithelial cell-derived exosome inhibits angiogenesis in ocular pathological neovascularization through its delivery of miR-146a-5p

  • FASEB J. 2023 Oct;37(10):e23192. doi: 10.1096/fj.202301020RR.
Ting Pan  1  2 Yan Wu  1 Xu Zhang  1 Jingfan Wang  1 Xingxing Wang  1 Qinyuan Gu  1 Changlin Xu  1 Yuanyuan Fan  1 Xinsheng Li  1  3 Ping Xie  1 Qinghuai Liu  1 Zizhong Hu  1
Affiliations
  • 1. Department of Ophthalmology, The First Affiliated Hospital of Nanjing Medical University, Nanjing, China.
  • 2. Department of Ophthalmology, The Affiliated Changzhou No. 2 People's Hospital of Nanjing Medical University, Changzhou, China.
  • 3. Department of Ophthalmology, The Affiliated Taizhou People's Hospital of Nanjing Medical University, Taizhou, China.
Abstract

Abnormal ocular neovascularization, a major pathology of eye diseases, leads to severe visual loss. The role of lens epithelial cell (LEC)-derived exosomes (Lec-exo) is largely unknown. Thus, we aimed to investigate whether Lec-exo can inhibit abnormal ocular neovascularization and explore the possible mechanisms. In our study, we proved the first evidence that exosomes derived from LECs attenuated angiogenesis in both oxygen-induced retinopathy and laser-induced choroidal neovascularization mice models. Further in vitro experiments proved that Lec-exo inhibited proliferation, migration, and tube formation capability of human umbilical vein endothelial cells in high glucose condition. Further high-throughput miRNAs Sequencing analysis detected that miR-146a-5p was enriched in Lec-exo. Mechanistically, exosomal miR-146a-5p was delivered to endothelial cells and bound to the NRAS coding sequence, which subsequently inactivated Akt/ERK signaling pathway. We successfully elucidated the function of Lec-exo in inhibiting abnormal ocular neovascularization, which may offer a promising strategy for treatment of abnormal ocular neovascularization.

Keywords
exosome; lens epithelial cell; miRNA; ocular neovascularization.
Products